FDA Warning Letter — Teligent Pharma, Inc.
The FDA took a Warning Letter action against Teligent Pharma, Inc. on Nov 26, 2019 (Buena, NJ). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Teligent Pharma, Inc.
- Date
- Nov 26, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Center
- CDER
- Location
- Buena, NJ (United States)